Identification of 5-hydroxytryptamine1A receptor agents using a composite pharmacophore analysis and chemical database screening
Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie - Tập 343 - Trang 109-116 - 1991
Tóm tắt
A composite pharmacophore analysis and computer-assisted chemical database screening were used to identify a previously unrecognized class of 5-hydroxytryptamine1A (5-HT1A) receptor active agents. An analysis of published data led to the identification of 20 different chemical structures which share nanomolar affinity for the 5-HT1A receptor. From a composite pharmacophore analysis of all 20 potent agents, we hypothesized that compounds containing a novel (in terms of 5-HT1A receptor analysis) 3 ring structure might be active at the 5-HT1A receptor. To test this hypothesis, the Chemical Abstracts database, which contains over 10 million compounds, was screened electronically for compounds that contain this core structure. A series of 319 agents was identified which contain this core structure. A total of 6 compounds was then obtained commercially and evaluated in radioligand binding studies. A single agent (Compound 69/183) conformed most closely to the composite 5-HT1A pharmacophore and displayed an affinity of 20 nmol/l for the 5-HT1A receptor binding site. Two other agents displayed affinities of 170 and 500 nmol/l, respectively, for the 5-HT1A receptor site. The 3 agents which differed most significantly from the composite 5-HT1A pharmacophore displayed affinities of 1,200− > 10,000 nmol/l for the 5-HT1A receptor binding site. These data suggest that a composite pharmacophore analysis and computer-assisted chemical database screening can be an effective technique for the identification of previously unrecognized receptor active agents.
Tài liệu tham khảo
Arnt J, Hyttel J (1989) Facilitation of 8-OH-DPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Eur J Pharmacol 161:45–51
Cossery JM, Gozlan H, Spampinato U, Perdicakis C, Guillaumet G, Pichat L, Hamon M (1987) The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino) chroman. Eur J Pharmacol 140:143–155
Dompert WU, Glaser T, Traber J (1985) 3H-TVX Q 7821: Identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn-Schmiedeberg's Arch Pharmacol 328:467–470
Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ (1988) The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335:358–360
Fozard JR, Mir AK, Middlemiss DN (1987) Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: Site of action and pharmacological analysis. J Cardiovasc Pharmacol 9:328–347
Glennon RA, Naiman NA, Lyon RA, Titeler M (1988) Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands. J Med Chem 31:1968–1971
Gozlan H, Mestikawy SE, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140–142
Gozlan H, Penchant M, Daval G, Verge D, Menard F, Vanhove A, Beaucourt JP, Hamon M (1987) 125I-Bolton-hunter-8-methoxy-2-[N-propyl-n-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro and autoradiographic studies. J Pharm Exp Ther 244:751–759
Hall MD, Gozlan H, Emerit MB, Mestikawy SE, Pichat L, Hamon M (1986) Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Neurochem Res 11:891–912
Hall MD, Mestikawy E S. E, B. M, Pichat L, Hamon M, Gozlan H (1985) [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44:1685–1696
Hamon M, Cossery J-M, Spampinato U, Gozlan H (1986) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? TIPS 7:336–338
Hibert MF, Gittos MW, Middlemiss DN, Mir AK, Fozard JR (1988) Graphics computer-aided receptor mapping as a predictive tool for drug design: Development of potent, selective, and stereospecific ligands for the 5-HT1A receptor. J Med Chem 31:1087–1093
Hibert MF, McDermott I, Middlemiss DN, Mir AK, Fozard JR (1989) Radioligand binding study of a series of 5-HT1A receptor agonists and definition of a steric model of this site. Eur J Med Chem 24:31–37
Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8OH-DPAT, (−) [125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Kwong LL, Davidson JM, Smith ER, Peroutka SJ (1986) Differential interaction of “prosexual” drugs with 5-hydroxytryptamine1A and alpha2-adrenergic receptors. Behav Neurosci 100:664–668
Lloyd EJ, Andrews PR (1986) A common structural model for cental nervous system drugs and their receptors. J Med Chem 29:453–462
Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(DI-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151–153
Morrow AL, Norman AB, Battaglia G, Loy R, Creese I (1985) Upregulation of serotonergic binding sites labeled by (3H)WB4101 following fimbrial transection and 5,7-dihydroxy-tryptamineinduced lesions. Life Sci 37:1913–1922
Nelson DL, Monroe PJ; Lambert G, Yamamura HI (1987) [3H]Spiroxatrine labels a serotonin1A-like site in the rat hippocampus. Life Sci 41:1567–1576
Norman AB, Battaglia G, Morrow AL, Creese I (1985) [3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex. Eur J Pharmacol 106:461–462
Peroutka SJ (1985) Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain. Brain Res 344:167–171
Peroutka SJ (1986a) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B and 5-HT1C binding site in rat cortex. J Neurochem 47:529–540
Peroutka SJ (1986b) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47:529–540
Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11:45–60
Ransom RW, Asarch KB, Shih JC (1985) A trifluoromethylphenyl piperazine derivative with high affinity of 5-hydroxytryptamine-1A sites in rat brain. J Neurochem 44:875–880
Schlegel JR, Peroutka SJ (1986) Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino) tetralin ([3H]-8-OH-DPAT). Biochem Pharmacol 35:1943–1949
Schoeffter P, Hoyer D (1988) Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol 95:975–985
Schoemaker H, Langer SZ (1986) [3H]8-OH-DPAT Labels the scrotonin transporter in the rat striatum. Eur J Pharmacol 124:371–373
Taylor EW, Nikam S, Week B, Martin A, Nelson D (1987) Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites. Life Sci 41:1961–1969
Titeler M, Lyon RA, Davis KH, Glennon RA (1987) Selectivity of serotonergic drugs for multiple brain serotonin receptors. Biochem Pharmacol 36:3265–3271
Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213–216
Wander TJ, Nelson A, Okazaki H, Richelson E (1987) Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro. Eur J Pharmacol 143:279–282